Abiomed CEO on Blowout Earnings

Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.

CNBC | February 7, 2012

Tags:. .blowout. .minogue. .expensive. .ultra. .ceo